Truex Samantha has filed 7 insider transactions across 1 company since August 2024.
Most recent transaction: a option exercise of 3166 shares of Avalo Therapeutics, Inc. ($AVTX) on March 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 28, 2026 | Avalo Therapeutics, Inc. | $AVTX | Truex Samantha | Not found | M | Common Stock | 3166 | $0.00 | 6,333.0000 | 18,133,968 | 99.97% | 0.02% |
| March 28, 2026 | Avalo Therapeutics, Inc. | $AVTX | Truex Samantha | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| June 17, 2025 | Avalo Therapeutics, Inc. | $AVTX | Truex Samantha | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| March 28, 2025 | Avalo Therapeutics, Inc. | $AVTX | Truex Samantha | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| March 28, 2025 | Avalo Therapeutics, Inc. | $AVTX | Truex Samantha | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| Aug. 13, 2024 | Avalo Therapeutics, Inc. | $AVTX | Truex Samantha | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Avalo Therapeutics, Inc. | $AVTX | Truex Samantha | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |